Eva Bustamante

420 total citations
19 papers, 268 citations indexed

About

Eva Bustamante is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eva Bustamante has authored 19 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eva Bustamante's work include Global Cancer Incidence and Screening (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer Diagnosis and Treatment (2 papers). Eva Bustamante is often cited by papers focused on Global Cancer Incidence and Screening (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer Diagnosis and Treatment (2 papers). Eva Bustamante collaborates with scholars based in Chile, Spain and United States. Eva Bustamante's co-authors include Christian Rolfo, Christian Caglevic, Cristian Soza‐Ried, Rafael Sirera, Gareth I. Owen, Ricardo D. Moreno, Fernando D. González‐Nilo, Luís Velásquez, Jeffrey Comer and María Loreto Bravo and has published in prestigious journals such as Biomaterials, Fertility and Sterility and eLife.

In The Last Decade

Eva Bustamante

18 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Bustamante Chile 9 76 68 48 44 40 19 268
Zhaohuan Li China 14 84 1.1× 75 1.1× 97 2.0× 50 1.1× 26 0.7× 27 415
Stephen J. Evans United Kingdom 12 43 0.6× 78 1.1× 143 3.0× 23 0.5× 44 1.1× 25 414
H. Leppens Belgium 10 85 1.1× 72 1.1× 117 2.4× 24 0.5× 20 0.5× 16 458
Yuhan Ma China 8 67 0.9× 127 1.9× 106 2.2× 16 0.4× 16 0.4× 17 472
You Fu China 11 18 0.2× 128 1.9× 46 1.0× 47 1.1× 39 1.0× 23 373
Maxime Annereau France 9 24 0.3× 70 1.0× 78 1.6× 103 2.3× 29 0.7× 39 321
Susana C. Hilderbrand United States 8 33 0.4× 95 1.4× 64 1.3× 11 0.3× 45 1.1× 8 425
Jolanta Jedrzkiewicz United States 7 89 1.2× 52 0.8× 87 1.8× 22 0.5× 39 1.0× 19 288
Pu Shao China 8 38 0.5× 111 1.6× 70 1.5× 16 0.4× 14 0.3× 15 317

Countries citing papers authored by Eva Bustamante

Since Specialization
Citations

This map shows the geographic impact of Eva Bustamante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bustamante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bustamante more than expected).

Fields of papers citing papers by Eva Bustamante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Bustamante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bustamante. The network helps show where Eva Bustamante may publish in the future.

Co-authorship network of co-authors of Eva Bustamante

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Bustamante. A scholar is included among the top collaborators of Eva Bustamante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Bustamante. Eva Bustamante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Marcelain, Katherine, Benjamín García‐Bloj, Eva Bustamante, et al.. (2023). Avances y desafíos locales en el diagnóstico molecular de tumores sólidos: una mirada sanitaria hacia la oncología de precisión en Chile. Revista médica de Chile. 151(10). 1344–1360. 3 indexed citations
2.
Becerra, Sergio, et al.. (2022). Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial. World Journal of Clinical Oncology. 13(10). 813–821.
3.
Young, Rodrigo, Eva Bustamante, Cecilia Tapia, et al.. (2021). Smartphone screen testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals. eLife. 10. 7 indexed citations
4.
Ríos, Juvenal A., Katherine Marcelain, Francisca Plaza-Parrochia, et al.. (2021). Planificación sanitaria a partir de los datos ómicos: ¿es posible esta idea para Chile?. Revista médica de Chile. 149(11). 1657–1663. 1 indexed citations
5.
Bustamante, Eva, Shrikant I. Bangdiwala, Ivonne I. Flores, et al.. (2021). Pharmacogenetics–Based Preliminary Algorithm to Predict the Incidence of Infection in Patients Receiving Cytotoxic Chemotherapy for Hematological Malignancies: A Discovery Cohort. Frontiers in Pharmacology. 12. 1 indexed citations
6.
7.
8.
Soza‐Ried, Cristian, et al.. (2019). Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor. Critical Reviews in Oncology/Hematology. 139. 128–133. 45 indexed citations
9.
Romieu, Isabelle, Carine Biessy, Gabriela Torres-Mejı́a, et al.. (2019). Project profile: a multicenter study on breast cancer in young women in Latin America (PRECAMA study). Salud Pública de México. 61(5, sep-oct). 601–601. 7 indexed citations
10.
Adolphe, Christelle, Pablo Lois, Eva Bustamante, et al.. (2017). Downregulation of the Sonic Hedgehog/Gli pathway transcriptional target Neogenin-1 is associated with basal cell carcinoma aggressiveness. Oncotarget. 8(48). 84006–84018. 8 indexed citations
11.
Jara, Jorge Jiménez de la, Gabriel Bastías, Catterina Ferreccio, et al.. (2015). A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy. Biological Research. 48(1). 10–10. 25 indexed citations
12.
Caglevic, Christian, Massimiliano Grassi, Luis E. Raez, et al.. (2015). Nintedanib in non-small cell lung cancer: from preclinical to approval. Therapeutic Advances in Respiratory Disease. 9(4). 164–172. 31 indexed citations
13.
Trapé, Jaume, et al.. (2014). Clinical utility of determining tumor markers in patients with signs and symptoms of cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 53(3). 485–91. 8 indexed citations
14.
Vilos, Cristián, Fernando D. González‐Nilo, Jeffrey Comer, et al.. (2013). Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 34(16). 4098–4108. 84 indexed citations
15.
Garrido, Marcelo, Sumie Kato, María Loreto Bravo, et al.. (2013). Potencial herramienta en la personalización del tratamiento oncológico: Casos clínicos. Revista médica de Chile. 141(5). 669–673. 1 indexed citations
16.
Moreno, Ricardo D., Eva Bustamante, Gerald Schatten, & C. Barros. (2002). Inhibition of mouse in vitro fertilization by an antibody against a unique 18-amino acid domain in the polysulfate-binding domain of proacrosin/acrosin. Fertility and Sterility. 77(4). 812–817. 13 indexed citations
17.
Palomino, Jaime, et al.. (2002). Egg coats of the rock shrimp Rhynchocinetes typus: ultrastructural characterization and their function during fertilization. Journal of Experimental Zoology. 293(6). 632–640. 3 indexed citations
18.
Bustamante, Eva, et al.. (2001). Purification and biochemical characterization of a trypsin-like enzyme present in the sperm of the rock shrimp,Rhynchocinetes typus. Invertebrate Reproduction & Development. 39(3). 175–181. 8 indexed citations
19.
Calvet, Xavier, Eva Bustamante, Antónia Montserrat, et al.. (2000). Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test. European Journal of Gastroenterology & Hepatology. 12(8). 949–953. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaohuan Li Breakdown of academic impact, for papers by Stephen J. Evans Breakdown of academic impact, for papers by H. Leppens Breakdown of academic impact, for papers by Yuhan Ma Breakdown of academic impact, for papers by You Fu Breakdown of academic impact, for papers by Maxime Annereau Breakdown of academic impact, for papers by Susana C. Hilderbrand Breakdown of academic impact, for papers by Jolanta Jedrzkiewicz Breakdown of academic impact, for papers by Pu Shao
Rankless by CCL
2026